JANSSEN WILL TELECONFERENCE AHCPR CANCER PAIN GUIDELINES
Executive Summary
JANSSEN WILL TELECONFERENCE AHCPR CANCER PAIN GUIDELINES to 10 cities on April 21. Organized by Janssen and the American Pain Society, the teleconference will precede the annual meeting of the State Cancer Pain Initiatives on April 22-25. The program is part of an ongoing educational campaign by Janssen to educate both physicians and patients about treating chronic cancer pain. Janssen markets Duragesic, a transdermal fentanyl patch for chronic cancer pain.